Trial Details

COMPLETED
Basic Information
Clinical ID c15
Identifier NCT05781698
Trial Title Repurposing Fenofibrate in Modulating mTOR/NLRP3 Inflammasome in Patients With Ulcerative Colitis
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Inflammatory Bowel Diseases
Interventions DRUG: Mesalamine|DRUG: Fenofibrate
Participant Information
Sponsor Tanta University
City Tanta
Country/Region Egypt
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2023-03-20
Primary Completion Date 2024-10-20
Completion Date 2024-12-20